Marketresearchnews

Thursday 29 July 2021

Nerve Regeneration Market 2020 Analysis, Industry Size, Share Leaders, Current Status by Major vendors and Trends by Forecast to 2027

Global Nerve Regeneration Market is expected to register a CAGR of 11.34% to reach USD 12695.25 million by 2024. Nerve regeneration products are used to restore damaged nerves to their normal function, and this procedure is primarily used to treat peripheral nerve injuries. This market is witnessing high growth due to factors such as rising neurological disorders, increasing geriatric population prone to nerve-related diseases, and technological advancements.

Rising neurological disorders, increasing geriatric population susceptible to neurological diseases, and technological advancements in the field of nerve regeneration are expected to enhance the market growth. However, high cost and stringent regulatory framework are projected to restrain the market growth during the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1202

Key Players

The prominent players in the global nerve regeneration market are Boston Scientific Corporation, LivaNova PLC, Axogen Corporation, Integra LifeSciences, Abbott, Stryker Corporation, Nuvectra Corporation, NeuroPace, Polyganics, and Medtronic.

The players operating in the global nerve regeneration market are focusing on product launches, along with expanding their global footprints by entering untapped markets.

In April 2019, Polyganics increased its production capacity with a new facility at the Zernike Campus, Groningen, to enter a new phase of commercial and research and development (R&D) growth.
In June 2018, NeuroPace launched a Next-Generation RNS System, the world’s only brain-computer interface for the treatment of refractory epilepsy.

Market Dynamics

The rising neurological disorders have primarily driven the global nerve regeneration market. For instance, as per the statistics of World Health Organizations(WHO) in 2017, around 50 million people all over the world were affected by epilepsy. Various other factors, such as increasing geriatric population affected by neurological disorders and technological advancements, are also propelling the growth of the market. Moreover, the high cost of products and stringent regulatory framework are expected to hinder the market growth.

Market Segmentation

Global Nerve Regeneration Market has been segmented into Product, Application, and End User. Based on the product, the market has been segregated into neurostimulation & neuromodulation devices and biomaterials. On the basis of neurostimulation and neuromodulation devices, the market has been divided into internal neurostimulation devices and external neurostimulation devices. Neurostimulation and neuromodulation devices held a share of 4,764.96 USD million in 2018. Internal neurostimulation devices have been further bifurcated into spinal cord stimulation, deep brain stimulation, vagus nerve stimulation, sacral nerve stimulation, and gastric electrical stimulation. External neurostimulation devices have been further segmented into transcutaneous electrical nerve stimulation, transcranial magnetic stimulation. Biomaterials have also been classified as nerve conduits, nerve protectors, nerve wraps, and nerve connectors. Based on the application, the market has been categorized as neurostimulation and neuromodulation surgeries, direct nerve repair/neurorrhaphy, nerve grafting, stem cell therapy, and others. Neurostimulation and neuromodulation surgeries have been bifurcated into internal neurostimulation and neuromodulation surgeries, external neurostimulation, and neuromodulation surgeries. Nerve grafting has been further classified as autografts, allografts, and xenografts. Based on end-user, the market has been divided into end-user, hospitals & clinics, ambulatory surgery centers, and others

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/nerve-regeneration-market-1202

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Non-Invasive Monitoring Device Market Show Steady Growth: Study 2027

The Global Non-Invasive Monitoring Device Market is expected to register a CAGR of 6.80% and is anticipated to reach USD 21,586.2 Million by 2023. Monitoring the patient condition is one of the significant parts of any treatment process for any disease condition. Monitoring devices are playing a vital role in providing the best possible care to the patients. There are three types of monitoring devices; invasive, minimally invasive, and non-invasive monitoring devices. Non-invasive devices are in high demand from the healthcare providers as well as patients due to their advantages over invasive monitoring. Non-invasive monitors are very much different from invasive monitors in terms of their working principle. Non-invasive monitors do not require rupturing of skin and penetration of any device into the body of the patient. Non-invasive monitors have sensors attached which play an essential role in generating readings of the body vitals.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1506

The increasing prevalence of cardiovascular diseases, increasing adoption of non-invasive technology, increasing prevalence of neurovascular diseases, increasing geriatric population, and favorable reimbursement policies are the major drivers propelling market growth. However, the erroneous readings and stringent regulatory norms constrain the growth of the market.

Market Dynamics

According to a report published in 2015 by the Center for Disease Control and Prevention (CDC), every year, more than 630,000 Americans die from heart diseases. Moreover, according to a report published by the CDC, in 2017, nearly 30.3 million people have diabetes only in the US. That means, one person out of every ten people has diabetes. Increasing prevalence of cardiovascular diseases has created a unique demand for advanced non-invasive monitoring devices. Additionally, increasing risks and patients suffering from diabetes & obesity, developing technology, and growing demand for monitoring devices will fuel the growth of the market during the forecast period.

Segmentation

The global non-invasive monitoring device market has been segmented into type, modality, application, and end user. By type, the market has been segmented into cardiac monitoring devices (electrocardiography and cardiac output monitors), brain monitoring devices, blood pressure monitoring devices, anesthesia monitoring devices, and blood glucose monitoring devices. Based on modality, the market has been segregated into table-top devices and wearable devices. By application, the market has been divided into cardiology, neurology, and oncology. On the basis of end-user, the market has been classified as hospital & clinics, diagnostic centers, and research & academic institutes. The hospitals and clinics segment accounted for a market value of USD 5457.4 million in 2016.

Key Players

The prominent players in the global non-invasive monitoring device market are General Electric Company (US), Medtronic PLC (Ireland), KONINKLIJKE PHILIPS NV (Netherlands), Abbott (US), Omron Corporation (Japan), Vaso Corporation (US), Integrity Applications (Israel), CAS Medical Systems, Inc. (US), A&D Medical Inc. (Japan), Tensys Medical Inc (US), OrSense Ltd (Israel), CNSystems Medizintechnik AG (Austria), NIMedical (Israel) and Advanced Brain Monitoring, Inc (US).

Some of the key strategies followed by the players operating in the global non-invasive monitoring device market were innovation, product development, acquisition, and expansion.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/non-invasive-monitoring-device-market-1506

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Hydrocephalus Market Industry Production and Demand, Competition News and Trends Forecasts to 2027

The Global Hydrocephalus Market is growing at a healthy pace and is expected to be USD 1,348.00 million in 2017, at a CAGR of 4.4% during the forecast period 2018-2023.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1719

Hydrocephalus is a condition that characterized by buildup of cerebrospinal fluid (CSF) in the brain cavities (ventricles). The ventricles expand as a result of fluid accumulation, causing an abnormal increase in brain size. In normal conditions, the cerebrospinal fluid usually flows through the cavities of the brain and spinal column, but in hydrocephalus, the excessive CSF accumulation causes damage to the brain tissues, leading to a number of brain impairments. This condition can occur in any age, but it is more prevalent in infants and older adults. The increasing prevalence of hydrocephalus is directly responsible for the market growth. The major cause for this condition in children is found to be malnourishment of the fetus. this condition is mostly genetic however, it can also manifest in adults and is known as acquired hydrocephalus.

Shunting is a primary line of treatment for hydrocephalus. Shunting creates a bypass for the accumulated fluid to flow to other parts of the body. The increasing prevalence of traumatic brain injuries due to accidents and shifting patient preference towards minimally invasive surgeries in geriatric population are considered as the key factors that are projected to encourage the growth of the global hydrocephalus market in the coming years. In addition to this, the growing disposable income among consumers and the rapid development in the healthcare infrastructure are further predicted to enhance the growth of the overall market in the next few years.

Market Dynamics

The market for hydrocephalus is not very well developed due to lack of attention paid to the treatment of the disease. Following the development of shunts for draining the accumulated cerebrospinal fluid and scans to diagnose this condition, there have been improvements in terms of treatments to provide short-term relief to patients. However, there are efforts to develop treatments to address the disease at initial stages and this has ensured a positive growth trend for the market.

Further, Posttraumatic hydrocephalus (PTH) is a recurrent and serious complication that follows a traumatic brain injury (TBI). The prevalence of this condition varies greatly based on different criteria for its diagnosis. It can be caused by the blockage of normal cerebrospinal fluid (CSF) flow, overproduction of CSF, or insufficient absorption that result in excessive accumulation of CSF around the brain

The use of ICP devices is for measuring the fluid pressure within the brain which may be caused by trauma or other conditions. ICP monitoring has a significant importance in diagnostic and post-operative procedures with cranial injury as seen in cases of stroke, hydrocephalus, and trauma. According to the estimate of the Centers for Disease Control and Prevention (CDC) in 2017, more than 1.75 million traumatic brain injuries occur in North America, annually and these monitoring devices enable surgeons to save lives of patients with timely intervention and treatment. The increasing accidental cases causing traumatic brain injuries are going to act as drivers for the hydrocephalus market.

Segmentation

The global Hydrocephalus market is segmented on the basis of type, diagnostic, treatment, end user. On the basis the type, the market is segmented into congenital hydrocephalus, acquired hydrocephalus, normal-pressure hydrocephalus, ex-vacuo hydrocephalus. on the basis of the diagnostic, the market is segmented into CT scan – head, MRI, head ultrasound. on the basis of treatment, it is segmented into surgery – shunt insertion, ventriculostomy, medication. on the basis of end user, it is segmented into hospitals & clinics, diagnostic centres, academic institutions and research organizations

Regional Analysis

The global market for hydrocephalus is segmented on the basis of regions into Americas, Europe, Asia Pacific, and Middle East & Africa.

The Americas held the largest share of the global hydrocephalus market owing to the rising prevalence of hydrocephalus, the presence of a well-developed healthcare sector, and the major market players. The continuous increase in the number of Americans affected from hydrocephalus coupled with ongoing research in neuroscience aid to the market growth. On a regional basis, the Americas is divided into North America and South America. North America is estimated to lead due to the presence of developed economies such as the US and Canada within the region. South America, however, is estimated to have the faster growth.

Europe stands second in the global market due to the constant evaluation of various techniques by neurosurgeons for the improvement of hydrocephalus management, is expected to drive growth in this market. Moreover, shunt manufacturers are engaged in investment for development of novel and improved shunts in order to tackle the pitfalls associated with the existing designs. The child population, aging in between 0 and 14 years, is estimated to increase from 17.6% of the total population in 2013 to 18.4% of the total population by 2020. This provides favorable background for market growth in Europe.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/hydrocephalus-market-1719

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Healthcare IoT Security Market Size, Share, Demand, Financial Overview, Key Developments, Swot Analysis and Forecast to 2027

The Global Healthcare IoT Security Market is expected to register 39.44% CAGR and is anticipated to reach USD 130,629.55 Million by 2025. Individuals today are using various kinds of networked devices to learn more about their health and daily regime. Home monitoring of aging population related to medical emergencies and medical adherence has become possible due to the increasing use of mHealth applications and smart pills.

However, the rewards of IoT also comes with the aspect of concern regarding the security and the privacy of the patient healthcare data. Mobile and wearable devices, pacemakers, insulin pumps, and other medical systems in the IoT create more access points prone to hackers. The security solutions and services play a critical role for the healthcare organizations to perform vulnerability management and secure the protected health information passing from IoT devices to the healthcare organizations.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/946

Market Dynamics

The market for healthcare IoT security is expected to register double-digit growth during the forecast period. The major factors influencing the growth of the market include increased data privacy concerns among consumers, increased government concerns over healthcare IoT security, increased usage of smart devices for health management and increased proliferation of cybercrimes in healthcare.

With the emergence of IoT in healthcare, consumers can now track their health in real time and simultaneously share healthcare information with their caregivers and healthcare organizations. However, the ease and usage of these devices are also raising security concerns among consumers. As the use of IoT increases, data privacy concerns are bound to increase and hence, will act as a key driver for the healthcare IoT security market, globally.

Segmentation

The global healthcare IoT security market has been segmented into components, security type, application.

Based on component, the global market is divided into solution and service.

Based on solution type, the global market has been segmented into analytics, encryption, data loss protection, identity and access management, unified threat management, and others.

Based on service type, the global market has been segmented into consulting services, risk assessment services, design & integration services, managed security services, and others.

Based on security type, the global market is segmented into application security, cloud security, endpoint security, network security, others security.

Based on application, the global market is segmented into pharmaceutical, medical devices, and biotechnology.

Key Players

The prominent players in the global healthcare IoT security market are Inside Secure SA, IBM Corporation, Cisco Systems Inc., Intel Corporation, Oracle Corporation, Sophos Group plc, Symantec Corporation, Trend Micro Inc, Checkpoint Software Technology, Kaspersky Labs, Fortinet Inc, Intelen Inc, Eurotech SpA, Deutsche telekom AG, SecureFLO LLC, Dell Corporation, Atmel Corporation, Security Mentor, Klynveld Peat Marwick Goerdeler, Agile Cyber Security Solutions, LLC.

Some of the key strategies followed by the players operating in the global healthcare IoT security market are innovation, product development, acquisition, and expansion.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/healthcare-iot-security-market-946

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Intracranial Pressure (ICP) Monitoring Market Dynamics, Segments and Supply Demand 2020-2027

Intracranial pressure (ICP) monitoring is used in treating patients suffering from severe brain injury. In this process a sensor device is been used and placed inside the head to measure the pressure inside the skull and send it to a recording device

Intracranial pressure monitoring can be performed in following three ways:

Intraventricular Catheter: is the most accurate method. In this method Intraventricular Catheter is inserted through a hole in the skull and place in the lateral ventricle.

Subdural Screw: In this method hollow screw is placed in the skull. It is placed between a membrane that protects the spinal cord and the brain.

Epidural Sensor: The Epidural Sensor is placed between the skull and dural tissue by drilling a hole in the skull

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/703

Intracranial pressure monitoring (ICP) market Application:

Intracranial pressure (ICP) monitoring is mainly used in hospitals for patients suffering from brain injury, meningitis and intracerebral hemorrhage. There are multiple ICP products that have been used in hospitals such as Surgical Instruments, IAP-Monitoring, Hydrocephalus, CSF drainage and many more.

The microtransducers and ventriculostomy is included invasive method whereas tympanic membrane displacement, transcranial Doppler, CT scan/ MRI, optic nerve sheath diameter, and fundoscopy is included in noninvasive methods

Intracranial pressure (ICP) monitoring market growth influencer:

The major growth drivers of Intracranial pressure monitoring market is increasing global incidence and prevalence of neurological disorders, rising awareness about neurodegenerative diseases, technological advancements in brain monitoring devices and growing incidence of traumatic brain injuries.

The shortage of trained professionals, high cost of complex brain monitoring devices, unfavorable reimbursement policies and concerns regarding the accuracy of diagnostic devices are the major restraints of ICP market.

Intracranial pressure (ICP) monitoring market segmentation:

ICP monitoring market segmentation can be done by method, market, Instrument, applications and End-users.

ICP monitoring market by Method: Invasive and Non- invasive

ICP monitoring market by Market: external ventricular drain, fiber optic monitor, strain gauge transducer and air-pouch device market.

ICP monitoring market by Instrument: Devices and accessories

ICP monitoring market by Applications: Traumatic Brain Injury, Intracerebral Hemorrhage, Meningitis, and Subarachnoid Hemorrhage

ICP monitoring market by End-users: Trauma centers, hospitals, clinics and diagnostic laboratories.

Intracranial pressure (ICP) monitoring market major players:

Natus Medical Inc. (U.S.), Nihon Kohden Corporation (Japan), Philips Healthcare (Netherlands), GE Healthcare (U.K.), Siemens Healthcare (Germany), Compumedics Ltd. (Australia), Electrical Geodesics Incorporated (U.S.), Medtronic Inc. (Ireland), CAS Medical Systems, Inc. (U.S.) and Advanced Brain Monitoring (U.S.)

The reports also covers brief analysis of Geographical Region includes:

Americas: North America: US, Canada; Europe: Western Europe: Germany, France, Italy, Spain, U.K, Rest of Western Europe; Eastern Europe: Poland, Russia; Asia– Pacific: Asia: China, India, Japan, Rest of Asia; Pacific Countries: Australia, New Zealand; The Middle East& Africa.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/intracranial-pressure-monitoring-market-703

About US:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Clinical Laboratory Test Market Show Steady Growth: Study 2027

Scenario of Clinical Laboratory Test Market:

Clinical laboratory tests represent a case of high volume steady growth market. The global clinical laboratory test market is anticipated to develop to USD 324.5 billion by 2022 from USD 206.7 billion in 2016. The market is expected to generate a CAGR growth of 6.5% during the forecasted period of 2016 to 2022.

Market Dynamics of Clinical Laboratory test Market:

Drivers

The increasing prevalence of diseases and the growing population of the world is the critical driver of the market. The market is getting a boost from the growing screening programs initiated by the major governments. The inclusion of mandatory screening in the affordable healthcare act for newborns is expected to lead to a fast growth. Increasing awareness and growing bias towards evidence based medicines coupled with the growing volume of in-vitro diagnostic tests will also press the market growth.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1649

The advent of biotech based tests such as DNA based tests are a large market opportunity as they result in greater selectivity and sensitivity. Growing trends towards self-diagnostic tests is expected to make a positive contribution to the markets. Panel based tests are the latest market trend due to their ease of use and single use systems. Automation is another trend driving the market as newer instruments have the capacity and capability to be linked and synced with another instruments. One such glaring example, is that of high pressure liquid chromatography and mass spectroscopy systems which save time and efforts.

Restraints

Stringent government rules and regulations and the high costs of the tests are the critical constraints on the market. The presence of spurious low cost products is hampering the market due to customer’s loss of faith. False results are other restraints as many older tests have low selectivity and detection limits to their targets.

Segments of Clinical Laboratory test Market:

Laboratory type - hospital based laboratories, central/independent laboratories, physician office laboratory (pol) and others. The market segmented by laboratory type is dominated by the hospital based laboratories.

Laboratory tests - Complete Blood Count (CBC) and other routine blood tests, anatomic pathology, molecular tests, immunology tests, drug testing and others. On the basis of laboratory tests, CBC and other routine blood tests are expected to hold the largest market share.

Regional Analysis of Clinical Laboratory test Market:

North America is the largest market share holder accounting for 44.6% of global clinical laboratory test market and is expected to generate a CAGR growth of 6.2%. U.S. is expected to be the prime market share holder of North America clinical laboratory testing market generating an anticipated CAGR growth of 5.8%. Large number of laboratories and growing volume of clinical testing procedures are the prime reasons for the dominance of the U.S. Canada, is expected to be the fastest market in the North American region with an expected CAGR growth of 6.3%.

Europe is expected to be the second largest market for clinical laboratory test and is expected to generate a CAGR growth of 6.6%. Europe region is expected to be dominated by Germany owing to its highly developed medical device companies. Germany is expected to be followed by France and the U.K.

Asia-pacific region is expected to be the fastest growing market, with a growth rate of 6.5% to 7% on account of growing awareness, strengthening government support and growing healthcare infrastructure.

Key Players for Clinical Laboratory test Market:

Laboratory Corporation of America, LifeLabs Medical Laboratories, Sonic Healthcare, Aurora Diagnostics, Quest Diagnostics, and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/clinical-laboratory-test-market-1649

Wednesday 28 July 2021

Substance Abuse Treatment Market 2020 Global Trend, Segmentation And Opportunities - Forecast To 2027

Global substance abuse treatment market is expected to grow significantly over the forecast period. It is projected to grow at a CAGR of 11.6% over the forecast period.

Substance abuse refers to the harmful use of psychoactive substances, including alcohol and illicit drugs.

Increasing trends of cigarette smoking in teenagers is one of the prominent factors driving the Substance Abuse Treatment market. According to the 2015 study published in the Clinical and Translational Investigation journal, More than 60% of individuals start smoking at the age of 13 and more than 90% individuals start smoking before reaching 20 years. It is also reported that 5.8% of the Mexican population comprises adolescents between 13 and 15 years. Of them, 42.8% tried a cigarette at some point in their life.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7230

Various other factors such as increasing incidence of drug addiction, technological advancement in the diagnostics industry, rising patient awareness about substance abuse treatment and improvement in treatment rates and healthcare infrastructure are also expected to propel the growth of the market.

However, poor treatment compliance in some countries and reluctance of individuals for accessing treatment can hamper the market growth over the forecast period.

Segmentation

The global substance abuse treatment market is segmented based on abuse type, treatment type, end user, and region.

The global market for substance abuse treatment, by abuse type is segmented into alcohol dependence, tobacco/nicotine addiction, and drug abuse. The drug abuse segment is anticipated to hold the largest market share owing to the increasing addiction of opioid.

The market, by treatment type, is segmented into alcohol addiction treatment, tobacco/nicotine addiction treatment, and drug abuse treatment. The alcohol addiction treatment segment is further classified as disulfiram, acamprosate, and naltrexone. The tobacco/nicotine addiction treatment segment is further classified as nicotine replacement treatment, and non-nicotine medication. The nicotine replacement treatment segment includes nicotine patch, nicotine gum, nicotine lozenge, nicotine spray, and nicotine inhaler. The non-nicotine medication segment includes bupropion, and varenicline. The drug abuse treatment segment is further classified as methadone, buprenorphine, and naltrexone.

Based on end user, the market is segmented into outpatient treatment centres, residential treatment centres, and inpatient treatment centres.

In the current scope of the study, the above-mentioned segments are covered into the four global regions, namely the Americas, Europe, Asia-Pacific and the Middle East & African region.

The substance abuse treatment market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European substance abuse treatment market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The substance abuse treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The substance abuse treatment market in the Middle East & Africa has been segmented into the Middle East and Africa.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/substance-abuse-treatment-market-7230